144 related articles for article (PubMed ID: 38678957)
1. A new high-throughput screening methodology for the discovery of cancer-testis antigen using multi-omics data.
Li D; Xia L; Zhang X; Liu Y; Wang Z; Guo Q; Huang P; Leng W; Qin S
Comput Methods Programs Biomed; 2024 Jun; 250():108193. PubMed ID: 38678957
[TBL] [Abstract][Full Text] [Related]
2. Derepression of Cancer/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation.
Kim R; Kulkarni P; Hannenhalli S
BMC Cancer; 2013 Mar; 13():144. PubMed ID: 23522060
[TBL] [Abstract][Full Text] [Related]
3. Serine protease PRSS56, a novel cancer-testis antigen activated by DNA hypomethylation, promotes colorectal and gastric cancer progression via PI3K/AKT axis.
Li D; Xia L; Huang P; Wang Z; Guo Q; Huang C; Leng W; Qin S
Cell Biosci; 2023 Jul; 13(1):124. PubMed ID: 37400936
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation-activated cancer-testis gene LIN28B promotes cell proliferation and metastasis in gastric cancer.
Xu J; Zhou Y; Yang J; Gu Y; Zhang E; Yuan W; Wang C; Jin G; Ma H; Hu Z
Gene; 2022 Mar; 813():146115. PubMed ID: 34902508
[TBL] [Abstract][Full Text] [Related]
5. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
6. Integrative discovery of epigenetically derepressed cancer testis antigens in NSCLC.
Glazer CA; Smith IM; Ochs MF; Begum S; Westra W; Chang SS; Sun W; Bhan S; Khan Z; Ahrendt S; Califano JA
PLoS One; 2009 Dec; 4(12):e8189. PubMed ID: 19997593
[TBL] [Abstract][Full Text] [Related]
7. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
8. Methylation Profile of Cancer Testis Antigens in Colorectal Cancer.
Abu N; Rus Bakarurraini NAA; Nasir SN; Ishak M; Baharuddin R; Jamal R; Ab Mutalib NS
Iran J Immunol; 2023 Mar; 20(1):83-91. PubMed ID: 36932973
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma.
Cho B; Lee H; Jeong S; Bang YJ; Lee HJ; Hwang KS; Kim HY; Lee YS; Kang GH; Jeoung DI
Biochem Biophys Res Commun; 2003 Jul; 307(1):52-63. PubMed ID: 12849980
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
Yang P; Meng M; Zhou Q
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens.
Schirmer U; Fiegl H; Pfeifer M; Zeimet AG; Müller-Holzner E; Bode PK; Tischler V; Altevogt P
BMC Cancer; 2013 Mar; 13():156. PubMed ID: 23530769
[TBL] [Abstract][Full Text] [Related]
12. Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets.
Xie K; Fu C; Wang S; Xu H; Liu S; Shao Y; Gong Z; Wu X; Xu B; Han J; Xu J; Xu P; Jia X; Wu J
J Ovarian Res; 2019 Jan; 12(1):1. PubMed ID: 30609934
[TBL] [Abstract][Full Text] [Related]
13. ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
Seo EH; Kim HJ; Kim JH; Lim B; Park JL; Kim SY; Lee SI; Jeong HY; Song KS; Kim YS
Int J Cancer; 2020 Jun; 146(12):3354-3368. PubMed ID: 32129880
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic potential value of Cancer-testis antigens in immunotherapy of gastric cancer.
Alsadat Mahmoudian R; Amirhosein M; Mahmoudian P; Fardi Golyan F; Mokhlessi L; Maftooh M; Khazaei M; Nassiri M; Mahdi Hassanian S; Ghayour-Mobarhan M; Ferns GA; Shahidsales S; Avan A
Gene; 2023 Feb; 853():147082. PubMed ID: 36464170
[TBL] [Abstract][Full Text] [Related]
15. The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma.
Natsume A; Wakabayashi T; Tsujimura K; Shimato S; Ito M; Kuzushima K; Kondo Y; Sekido Y; Kawatsura H; Narita Y; Yoshida J
Int J Cancer; 2008 Jun; 122(11):2542-53. PubMed ID: 18240144
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
Kim KH; Choi JS; Kim IJ; Ku JL; Park JG
World J Gastroenterol; 2006 Sep; 12(35):5651-7. PubMed ID: 17007017
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; San Jose-Eneriz E; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
Haematologica; 2007 Feb; 92(2):153-62. PubMed ID: 17296563
[TBL] [Abstract][Full Text] [Related]
18. Expression of the human cancer/testis antigen NY-SAR-35 is activated by CpG island hypomethylation.
Park JH; Song MH; Lee CH; Lee MK; Park YM; Old L; Lee SY
Biotechnol Lett; 2011 Jun; 33(6):1085-91. PubMed ID: 21318630
[TBL] [Abstract][Full Text] [Related]
19. DNA hypomethylation promotes invasion and metastasis of gastric cancer cells by regulating the binding of SP1 to the CDCA3 promoter.
Yu J; Hua R; Zhang Y; Tao R; Wang Q; Ni Q
J Cell Biochem; 2020 Jan; 121(1):142-151. PubMed ID: 31211445
[TBL] [Abstract][Full Text] [Related]
20. Cancer-testis antigens in canine histiocytic sarcoma and other malignancies.
Nemec PS; Kapatos A; Holmes JC; Stowe DM; Hess PR
Vet Comp Oncol; 2019 Sep; 17(3):317-328. PubMed ID: 30854786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
